{
    "xml": "<topic id=\"PHP33907\" outputclass=\"drug\" rev=\"1.12\" type=\"drug\" namespace=\"/drugs/ponatinib\" basename=\"ponatinib\" title=\"PONATINIB\">\n<title>PONATINIB</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1270\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ponatinib\">Ponatinib</xref>\n</p>\n<data name=\"vtmid\">703798002</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_208007314\" title=\"Protein kinase inhibitors\">Protein kinase inhibitors</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP67427\" outputclass=\"indicationsAndDose\" rev=\"1.14\" parent=\"/drugs/ponatinib\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of chronic, accelerated, or blast phase chronic myeloid leukaemia in patients who have the T315I mutation or who have resistance to or intolerance of dasatinib or nilotinib, and for whom subsequent treatment with imatinib is not clinically appropriate</p>\n<p outputclass=\"therapeuticIndication\">Treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in patients who have the T315I mutation or who have resistance to or intolerance of dasatinib, and for whom subsequent treatment with imatinib is not clinically appropriate</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>45&#8239;mg once daily, for dose adjustment due to side effects&#8212;consult product literature.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseAdjustments\">\n<title>Dose adjustments due to interactions</title>\n<sectiondiv>\n<p>Consider reducing the initial dose to 30&#8239;mg once daily with concomitant use of potent inhibitors of cytochrome P450 enzyme CYP3A4 (e.g. clarithromycin, indinavir, itraconazole, ritonavir, saquinavir, telithromycin or voriconazole).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67477\" outputclass=\"importantSafetyInformation\" rev=\"1.21\" parent=\"/drugs/ponatinib\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"title\">MHRA/CHM advice: Ponatinib: risk of vascular occlusive events (November 2014)</p>\n<p>The benefits and risks of ponatinib have been reviewed by the European Medicines Agency's Committee on Medicinal Products for Human Use, which has recommended that strengthened warnings should be added to the product information aimed at minimising the risk of blood clots and blockages in the arteries. The review concluded that available evidence shows that the risk of blood vessel blockage with ponatinib is likely to be dose-dependent. However, the data is insufficient to recommend reducing the dose of ponatinib, and there is a risk that a lower dose might not be as effective as the current dose in all patients and in long-term treatment. Therefore, no change has been made to the recommended starting dose.</p>\n<p>Prescribers may wish to consider reducing the dose in patients with chronic phase chronic myeloid leukaemia who are responding well to treatment, and who might be at high risk of blood vessel blockage. Stop ponatinib if a complete response has not occurred within 3 months of treatment, and monitor patients for high blood pressure or signs of heart problems.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Risks of incorrect dosing of oral anti-cancer medicines</p>\n<p>The National Patient Safety Agency has advised (January 2008) that the prescribing and use of oral cytotoxic medicines should be carried out to the same standard as parenteral cytotoxic therapy.</p>\n<p>Standards to be followed to achieve this include:</p>\n<ul>\n<li>non-specialists who prescribe or administer on-going oral cytotoxic medication should have access to written protocols and treatment plans, including guidance on the monitoring and treatment of toxicity;</li>\n<li>staff dispensing oral cytotoxic medicines should confirm that the prescribed dose is appropriate for the patient. Patients should have written information that includes details of the intended oral anti-cancer regimen, the treatment plan, and arrangements for monitoring, taken from the original protocol from the initiating hospital. Staff dispensing oral cytotoxic medicines should also have access to this information, and to advice from an experienced cancer pharmacist in the initiating hospital.</li>\n</ul>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67504\" outputclass=\"cautions\" rev=\"1.23\" parent=\"/drugs/ponatinib\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Alcohol abuse&#8212;increased risk of pancreatitis</ph>; <ph outputclass=\"caution\">current severe hypertriglyceridaemia&#8212;increased risk of pancreatitis</ph>; <ph outputclass=\"caution\">discontinue treatment if a complete haematologic response has not occurred within 3 months</ph>; <ph outputclass=\"caution\">history of myocardial infarction&#8212;do not use unless potential benefit outweighs potential risk</ph>; <ph outputclass=\"caution\">history of pancreatitis</ph>; <ph outputclass=\"caution\">history of stroke&#8212;do not use unless potential benefit outweighs potential risk</ph>; <ph outputclass=\"caution\">hypertension&#8212;medically control during treatment and interrupt treatment if uncontrolled</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Cardiovascular status</p>\n<p>Assess cardiovascular status before treatment&#8212;manage cardiovascular risk factors before and during treatment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67417\" outputclass=\"interactions\" rev=\"1.13\" parent=\"/drugs/ponatinib\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (ponatinib).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67351\" outputclass=\"sideEffects\" rev=\"1.23\" parent=\"/drugs/ponatinib\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal discomfort</ph>; <ph outputclass=\"sideEffect\">altered sensations</ph>; <ph outputclass=\"sideEffect\">arthralgia</ph>; <ph outputclass=\"sideEffect\">atrial fibrillation</ph>; <ph outputclass=\"sideEffect\">biochemistry disturbances</ph>; <ph outputclass=\"sideEffect\">blurred vision</ph>; <ph outputclass=\"sideEffect\">bruising</ph>; <ph outputclass=\"sideEffect\">cardiac disorders</ph>; <ph outputclass=\"sideEffect\">cardiac events</ph>; <ph outputclass=\"sideEffect\">cerebrovascular events</ph>; <ph outputclass=\"sideEffect\">constipation</ph>; <ph outputclass=\"sideEffect\">cough</ph>; <ph outputclass=\"sideEffect\">decreased appetite</ph>; <ph outputclass=\"sideEffect\">dehydration</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">dry eyes</ph>; <ph outputclass=\"sideEffect\">dry mouth</ph>; <ph outputclass=\"sideEffect\">dry skin</ph>; <ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">dysphonia</ph>; <ph outputclass=\"sideEffect\">dyspnoea</ph>; <ph outputclass=\"sideEffect\">electrolyte disturbances</ph>; <ph outputclass=\"sideEffect\">epistaxis</ph>; <ph outputclass=\"sideEffect\">erectile dysfunction</ph>; <ph outputclass=\"sideEffect\">exfoliative dermatitis</ph>; <ph outputclass=\"sideEffect\">flushing</ph>; <ph outputclass=\"sideEffect\">gastro-oesophageal reflux disease</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hyperhidrosis</ph>; <ph outputclass=\"sideEffect\">hypertension</ph>; <ph outputclass=\"sideEffect\">infection</ph>; <ph outputclass=\"sideEffect\">insomnia</ph>; <ph outputclass=\"sideEffect\">intermittent claudication</ph>; <ph outputclass=\"sideEffect\">malaise</ph>; <ph outputclass=\"sideEffect\">muscle spasms</ph>; <ph outputclass=\"sideEffect\">musculoskeletal pain</ph>; <ph outputclass=\"sideEffect\">oedema</ph>; <ph outputclass=\"sideEffect\">pancreatitis</ph>; <ph outputclass=\"sideEffect\">pericardial effusion</ph>; <ph outputclass=\"sideEffect\">peripheral neuropathy</ph>; <ph outputclass=\"sideEffect\">pleural effusion</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">pyrexia</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">thromboembolic events</ph>; <ph outputclass=\"sideEffect\">vascular occlusion</ph>; <ph outputclass=\"sideEffect\">weight loss</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Atrial flutter</ph>; <ph outputclass=\"sideEffect\">cerebral artery stenosis</ph>; <ph outputclass=\"sideEffect\">cerebral infarction</ph>; <ph outputclass=\"sideEffect\">gastric haemorrhage</ph>; <ph outputclass=\"sideEffect\">hepatotoxicity</ph>; <ph outputclass=\"sideEffect\">jaundice</ph>; <ph outputclass=\"sideEffect\">retinal vein occlusion</ph>; <ph outputclass=\"sideEffect\">retinal vein thrombosis</ph>; <ph outputclass=\"sideEffect\">visual impairment</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Alopecia</ph>; <ph outputclass=\"sideEffect\">bone-marrow suppression</ph>; <ph outputclass=\"sideEffect\">hyperuricaemia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">oral mucositis</ph>; <ph outputclass=\"sideEffect\">thromboembolism</ph>; <ph outputclass=\"sideEffect\">tumour lysis syndrome</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67494\" outputclass=\"conceptionAndContraception\" parent=\"/drugs/ponatinib\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Exclude pregnancy before treatment with cytotoxic drugs.</p>\n<p>Contraceptive advice should be given to men and women before cytotoxic therapy begins (and should cover the duration of contraception required after therapy has ended)&#8212;ensure effective contraception during treatment in men and women; effectiveness of hormonal contraception unknown&#8212;alternative or additional methods of contraception should be used.</p>\n<p>Regimens that do not contain an alkylating drug or procarbazine may have less effect on fertility, but those with an alkylating drug or procarbazine carry the risk of causing permanent male sterility (there is no effect on potency). Pretreatment counselling and consideration of sperm storage may be appropriate. Women are less severely affected, though the span of reproductive life may be shortened by the onset of a premature menopause. No increase in fetal abnormalities or abortion rate has been recorded in patients who remain fertile after cytotoxic chemotherapy.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67400\" outputclass=\"pregnancy\" parent=\"/drugs/ponatinib\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid&#8212;toxicity in<i> animal</i> studies.</p>\n<p>Most cytotoxic drugs are teratogenic and should not be administered during pregnancy, especially during the first trimester.</p>\n<p>Considerable caution is necessary if a pregnant woman presents with cancer requiring chemotherapy, and specialist advice should always be sought.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67514\" outputclass=\"breastFeeding\" parent=\"/drugs/ponatinib\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises discontinue breastfeeding&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67442\" outputclass=\"hepaticImpairment\" parent=\"/drugs/ponatinib\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution in severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67379\" outputclass=\"renalImpairment\" parent=\"/drugs/ponatinib\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>No information available&#8212;manufacturer advises caution if creatinine clearance less than 50&#8239;mL/minute.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67315\" outputclass=\"monitoringRequirements\" parent=\"/drugs/ponatinib\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor serum lipase every 2 weeks for the first 2 months and periodically thereafter for all patients&#8212;withhold treatment if lipase elevated and abdominal symptoms occur.</p>\n<p>Monitor full blood count every 2 weeks for the first 3 months and then monthly thereafter or as clinically indicated.</p>\n<p>Monitor liver function periodically.</p>\n<p>Monitor for vascular occlusion or thromboembolism&#8212;interrupt treatment immediately if this occurs.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP33907-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/ponatinib\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75594\" title=\"Tablet\" namespace=\"/drugs/ponatinib/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e100887\" href=\"#bnf_d1e100887\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ponatinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e100887</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e100940\" href=\"#bnf_d1e100940\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ponatinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e100940</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e100963\" href=\"#bnf_d1e100963\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ponatinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e100963</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e101085\" href=\"#bnf_d1e101085\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ponatinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e101085</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e101108\" href=\"#bnf_d1e101108\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ponatinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e101108</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e101148\" href=\"#bnf_d1e101148\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ponatinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e101148</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e101171\" href=\"#bnf_d1e101171\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ponatinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e101171</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e18392\" href=\"#bnf_d1e18392\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/macrolides/clarithromycin\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e18392</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_168\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/macrolides/clarithromycin\" title=\"Clarithromycin\" count=\"1\" rel=\"backlink\">Clarithromycin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e58486\" href=\"#bnf_d1e58486\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/itraconazole\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e58486</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_302\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/itraconazole\" title=\"Itraconazole\" count=\"1\" rel=\"backlink\">Itraconazole</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e77847\" href=\"#bnf_d1e77847\" namespace=\"/interactions/list-of-drug-interactions/antivirals/indinavir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e77847</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_398\" namespace=\"/interactions/list-of-drug-interactions/antivirals/indinavir\" title=\"Indinavir\" count=\"1\" rel=\"backlink\">Indinavir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e80680\" href=\"#bnf_d1e80680\" namespace=\"/interactions/list-of-drug-interactions/antivirals/ritonavir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e80680</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_400\" namespace=\"/interactions/list-of-drug-interactions/antivirals/ritonavir\" title=\"Ritonavir\" count=\"1\" rel=\"backlink\">Ritonavir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e82196\" href=\"#bnf_d1e82196\" namespace=\"/interactions/list-of-drug-interactions/antivirals/saquinavir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e82196</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_791\" namespace=\"/interactions/list-of-drug-interactions/antivirals/saquinavir\" title=\"Saquinavir\" count=\"1\" rel=\"backlink\">Saquinavir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e15839\" href=\"#bnf_d1e15839\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/telithromycin\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e15839</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_946\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/telithromycin\" title=\"Telithromycin\" count=\"1\" rel=\"backlink\">Telithromycin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e56361\" href=\"#bnf_d1e56361\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/voriconazole\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e56361</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_948\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/voriconazole\" title=\"Voriconazole\" count=\"1\" rel=\"backlink\">Voriconazole</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1270\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ponatinib\" title=\"Ponatinib\" count=\"1\" rel=\"link\">Ponatinib</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75594\" namespace=\"/drugs/ponatinib/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP33907",
    "outputclass": "drug",
    "rev": "1.12",
    "type": "drug",
    "namespace": "/drugs/ponatinib",
    "basename": "ponatinib",
    "title": "PONATINIB",
    "interactants": [
        {
            "id": "bnf_int_1270",
            "label": "Ponatinib"
        }
    ],
    "vtmid": "703798002",
    "drugClassification": [
        "Protein kinase inhibitors"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment of chronic, accelerated, or blast phase chronic myeloid leukaemia in patients who have the T315I mutation or who have resistance to or intolerance of dasatinib or nilotinib, and for whom subsequent treatment with imatinib is not clinically appropriate",
                        "html": "Treatment of chronic, accelerated, or blast phase chronic myeloid leukaemia in patients who have the T315I mutation or who have resistance to or intolerance of dasatinib or nilotinib, and for whom subsequent treatment with imatinib is not clinically appropriate"
                    },
                    {
                        "textContent": "Treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in patients who have the T315I mutation or who have resistance to or intolerance of dasatinib, and for whom subsequent treatment with imatinib is not clinically appropriate",
                        "html": "Treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in patients who have the T315I mutation or who have resistance to or intolerance of dasatinib, and for whom subsequent treatment with imatinib is not clinically appropriate"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "45 mg once daily, for dose adjustment due to side effects&#8212;consult product literature.",
                        "html": "<p>45&#8239;mg once daily, for dose adjustment due to side effects&#8212;consult product literature.</p>"
                    }
                ]
            }
        ],
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "title": "Dose adjustments due to interactions",
                "textContent": "Consider reducing the initial dose to 30 mg once daily with concomitant use of potent inhibitors of cytochrome P450 enzyme CYP3A4 (e.g. clarithromycin, indinavir, itraconazole, ritonavir, saquinavir, telithromycin or voriconazole).",
                "html": "<p>Consider reducing the initial dose to 30&#8239;mg once daily with concomitant use of potent inhibitors of cytochrome P450 enzyme CYP3A4 (e.g. clarithromycin, indinavir, itraconazole, ritonavir, saquinavir, telithromycin or voriconazole).</p>"
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "title": "MHRA/CHM advice: Ponatinib: risk of vascular occlusive events (November 2014)",
                "textContent": "The benefits and risks of ponatinib have been reviewed by the European Medicines Agency's Committee on Medicinal Products for Human Use, which has recommended that strengthened warnings should be added to the product information aimed at minimising the risk of blood clots and blockages in the arteries. The review concluded that available evidence shows that the risk of blood vessel blockage with ponatinib is likely to be dose-dependent. However, the data is insufficient to recommend reducing the dose of ponatinib, and there is a risk that a lower dose might not be as effective as the current dose in all patients and in long-term treatment. Therefore, no change has been made to the recommended starting dose.\n\nPrescribers may wish to consider reducing the dose in patients with chronic phase chronic myeloid leukaemia who are responding well to treatment, and who might be at high risk of blood vessel blockage. Stop ponatinib if a complete response has not occurred within 3 months of treatment, and monitor patients for high blood pressure or signs of heart problems.",
                "html": "<p>The benefits and risks of ponatinib have been reviewed by the European Medicines Agency's Committee on Medicinal Products for Human Use, which has recommended that strengthened warnings should be added to the product information aimed at minimising the risk of blood clots and blockages in the arteries. The review concluded that available evidence shows that the risk of blood vessel blockage with ponatinib is likely to be dose-dependent. However, the data is insufficient to recommend reducing the dose of ponatinib, and there is a risk that a lower dose might not be as effective as the current dose in all patients and in long-term treatment. Therefore, no change has been made to the recommended starting dose.</p><p>Prescribers may wish to consider reducing the dose in patients with chronic phase chronic myeloid leukaemia who are responding well to treatment, and who might be at high risk of blood vessel blockage. Stop ponatinib if a complete response has not occurred within 3 months of treatment, and monitor patients for high blood pressure or signs of heart problems.</p>"
            },
            {
                "type": "importantSafetyInformation",
                "title": "Risks of incorrect dosing of oral anti-cancer medicines",
                "textContent": "The National Patient Safety Agency has advised (January 2008) that the prescribing and use of oral cytotoxic medicines should be carried out to the same standard as parenteral cytotoxic therapy.\n\nStandards to be followed to achieve this include:\n\nnon-specialists who prescribe or administer on-going oral cytotoxic medication should have access to written protocols and treatment plans, including guidance on the monitoring and treatment of toxicity; staff dispensing oral cytotoxic medicines should confirm that the prescribed dose is appropriate for the patient. Patients should have written information that includes details of the intended oral anti-cancer regimen, the treatment plan, and arrangements for monitoring, taken from the original protocol from the initiating hospital. Staff dispensing oral cytotoxic medicines should also have access to this information, and to advice from an experienced cancer pharmacist in the initiating hospital.",
                "html": "<p>The National Patient Safety Agency has advised (January 2008) that the prescribing and use of oral cytotoxic medicines should be carried out to the same standard as parenteral cytotoxic therapy.</p><p>Standards to be followed to achieve this include:</p><ul>\n<li>non-specialists who prescribe or administer on-going oral cytotoxic medication should have access to written protocols and treatment plans, including guidance on the monitoring and treatment of toxicity;</li>\n<li>staff dispensing oral cytotoxic medicines should confirm that the prescribed dose is appropriate for the patient. Patients should have written information that includes details of the intended oral anti-cancer regimen, the treatment plan, and arrangements for monitoring, taken from the original protocol from the initiating hospital. Staff dispensing oral cytotoxic medicines should also have access to this information, and to advice from an experienced cancer pharmacist in the initiating hospital.</li>\n</ul>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Alcohol abuse&#8212;increased risk of pancreatitis",
                "html": "Alcohol abuse&#8212;increased risk of pancreatitis"
            },
            {
                "type": "cautions",
                "textContent": "current severe hypertriglyceridaemia&#8212;increased risk of pancreatitis",
                "html": "current severe hypertriglyceridaemia&#8212;increased risk of pancreatitis"
            },
            {
                "type": "cautions",
                "textContent": "discontinue treatment if a complete haematologic response has not occurred within 3 months",
                "html": "discontinue treatment if a complete haematologic response has not occurred within 3 months"
            },
            {
                "type": "cautions",
                "textContent": "history of myocardial infarction&#8212;do not use unless potential benefit outweighs potential risk",
                "html": "history of myocardial infarction&#8212;do not use unless potential benefit outweighs potential risk"
            },
            {
                "type": "cautions",
                "textContent": "history of pancreatitis",
                "html": "history of pancreatitis"
            },
            {
                "type": "cautions",
                "textContent": "history of stroke&#8212;do not use unless potential benefit outweighs potential risk",
                "html": "history of stroke&#8212;do not use unless potential benefit outweighs potential risk"
            },
            {
                "type": "cautions",
                "textContent": "hypertension&#8212;medically control during treatment and interrupt treatment if uncontrolled",
                "html": "hypertension&#8212;medically control during treatment and interrupt treatment if uncontrolled"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Cardiovascular status",
                "textContent": "Assess cardiovascular status before treatment&#8212;manage cardiovascular risk factors before and during treatment.",
                "html": "<p>Assess cardiovascular status before treatment&#8212;manage cardiovascular risk factors before and during treatment.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (ponatinib).",
                "html": "<p>Appendix 1 (ponatinib).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Abdominal discomfort",
                        "html": "Abdominal discomfort",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "altered sensations",
                        "html": "altered sensations",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "arthralgia",
                        "html": "arthralgia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "atrial fibrillation",
                        "html": "atrial fibrillation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "biochemistry disturbances",
                        "html": "biochemistry disturbances",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "blurred vision",
                        "html": "blurred vision",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "bruising",
                        "html": "bruising",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "cardiac disorders",
                        "html": "cardiac disorders",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "cardiac events",
                        "html": "cardiac events",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "cerebrovascular events",
                        "html": "cerebrovascular events",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "constipation",
                        "html": "constipation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "cough",
                        "html": "cough",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "decreased appetite",
                        "html": "decreased appetite",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dehydration",
                        "html": "dehydration",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dry eyes",
                        "html": "dry eyes",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dry mouth",
                        "html": "dry mouth",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dry skin",
                        "html": "dry skin",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dyspepsia",
                        "html": "dyspepsia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dysphonia",
                        "html": "dysphonia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dyspnoea",
                        "html": "dyspnoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "electrolyte disturbances",
                        "html": "electrolyte disturbances",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "epistaxis",
                        "html": "epistaxis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "erectile dysfunction",
                        "html": "erectile dysfunction",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "exfoliative dermatitis",
                        "html": "exfoliative dermatitis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "flushing",
                        "html": "flushing",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "gastro-oesophageal reflux disease",
                        "html": "gastro-oesophageal reflux disease",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hyperhidrosis",
                        "html": "hyperhidrosis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hypertension",
                        "html": "hypertension",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "infection",
                        "html": "infection",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "insomnia",
                        "html": "insomnia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "intermittent claudication",
                        "html": "intermittent claudication",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "malaise",
                        "html": "malaise",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "muscle spasms",
                        "html": "muscle spasms",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "musculoskeletal pain",
                        "html": "musculoskeletal pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "oedema",
                        "html": "oedema",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pancreatitis",
                        "html": "pancreatitis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pericardial effusion",
                        "html": "pericardial effusion",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "peripheral neuropathy",
                        "html": "peripheral neuropathy",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pleural effusion",
                        "html": "pleural effusion",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pyrexia",
                        "html": "pyrexia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "thromboembolic events",
                        "html": "thromboembolic events",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vascular occlusion",
                        "html": "vascular occlusion",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "weight loss",
                        "html": "weight loss",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Atrial flutter",
                        "html": "Atrial flutter",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "cerebral artery stenosis",
                        "html": "cerebral artery stenosis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "cerebral infarction",
                        "html": "cerebral infarction",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "gastric haemorrhage",
                        "html": "gastric haemorrhage",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hepatotoxicity",
                        "html": "hepatotoxicity",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "jaundice",
                        "html": "jaundice",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "retinal vein occlusion",
                        "html": "retinal vein occlusion",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "retinal vein thrombosis",
                        "html": "retinal vein thrombosis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "visual impairment",
                        "html": "visual impairment",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Alopecia",
                        "html": "Alopecia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "bone-marrow suppression",
                        "html": "bone-marrow suppression",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hyperuricaemia",
                        "html": "hyperuricaemia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "oral mucositis",
                        "html": "oral mucositis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "thromboembolism",
                        "html": "thromboembolism",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "tumour lysis syndrome",
                        "html": "tumour lysis syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Exclude pregnancy before treatment with cytotoxic drugs.\n\nContraceptive advice should be given to men and women before cytotoxic therapy begins (and should cover the duration of contraception required after therapy has ended)&#8212;ensure effective contraception during treatment in men and women; effectiveness of hormonal contraception unknown&#8212;alternative or additional methods of contraception should be used.\n\nRegimens that do not contain an alkylating drug or procarbazine may have less effect on fertility, but those with an alkylating drug or procarbazine carry the risk of causing permanent male sterility (there is no effect on potency). Pretreatment counselling and consideration of sperm storage may be appropriate. Women are less severely affected, though the span of reproductive life may be shortened by the onset of a premature menopause. No increase in fetal abnormalities or abortion rate has been recorded in patients who remain fertile after cytotoxic chemotherapy.",
                "html": "<p>Exclude pregnancy before treatment with cytotoxic drugs.</p><p>Contraceptive advice should be given to men and women before cytotoxic therapy begins (and should cover the duration of contraception required after therapy has ended)&#8212;ensure effective contraception during treatment in men and women; effectiveness of hormonal contraception unknown&#8212;alternative or additional methods of contraception should be used.</p><p>Regimens that do not contain an alkylating drug or procarbazine may have less effect on fertility, but those with an alkylating drug or procarbazine carry the risk of causing permanent male sterility (there is no effect on potency). Pretreatment counselling and consideration of sperm storage may be appropriate. Women are less severely affected, though the span of reproductive life may be shortened by the onset of a premature menopause. No increase in fetal abnormalities or abortion rate has been recorded in patients who remain fertile after cytotoxic chemotherapy.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid&#8212;toxicity in animal studies.\n\nMost cytotoxic drugs are teratogenic and should not be administered during pregnancy, especially during the first trimester.\n\nConsiderable caution is necessary if a pregnant woman presents with cancer requiring chemotherapy, and specialist advice should always be sought.",
                "html": "<p>Avoid&#8212;toxicity in<i> animal</i> studies.</p><p>Most cytotoxic drugs are teratogenic and should not be administered during pregnancy, especially during the first trimester.</p><p>Considerable caution is necessary if a pregnant woman presents with cancer requiring chemotherapy, and specialist advice should always be sought.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises discontinue breastfeeding&#8212;no information available.",
                "html": "<p>Manufacturer advises discontinue breastfeeding&#8212;no information available.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution in severe impairment.",
                "html": "<p>Manufacturer advises caution in severe impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "No information available&#8212;manufacturer advises caution if creatinine clearance less than 50 mL/minute.",
                "html": "<p>No information available&#8212;manufacturer advises caution if creatinine clearance less than 50&#8239;mL/minute.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor serum lipase every 2 weeks for the first 2 months and periodically thereafter for all patients&#8212;withhold treatment if lipase elevated and abdominal symptoms occur.\n\nMonitor full blood count every 2 weeks for the first 3 months and then monthly thereafter or as clinically indicated.\n\nMonitor liver function periodically.\n\nMonitor for vascular occlusion or thromboembolism&#8212;interrupt treatment immediately if this occurs.",
                "html": "<p>Monitor serum lipase every 2 weeks for the first 2 months and periodically thereafter for all patients&#8212;withhold treatment if lipase elevated and abdominal symptoms occur.</p><p>Monitor full blood count every 2 weeks for the first 3 months and then monthly thereafter or as clinically indicated.</p><p>Monitor liver function periodically.</p><p>Monitor for vascular occlusion or thromboembolism&#8212;interrupt treatment immediately if this occurs.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75594",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "#bnf_d1e100887": [
            {
                "id": "bnf_d1e100887",
                "label": "bnf_d1e100887",
                "type": "#bnf_d1e100887"
            }
        ],
        "#bnf_d1e100940": [
            {
                "id": "bnf_d1e100940",
                "label": "bnf_d1e100940",
                "type": "#bnf_d1e100940"
            }
        ],
        "#bnf_d1e100963": [
            {
                "id": "bnf_d1e100963",
                "label": "bnf_d1e100963",
                "type": "#bnf_d1e100963"
            }
        ],
        "#bnf_d1e101085": [
            {
                "id": "bnf_d1e101085",
                "label": "bnf_d1e101085",
                "type": "#bnf_d1e101085"
            }
        ],
        "#bnf_d1e101108": [
            {
                "id": "bnf_d1e101108",
                "label": "bnf_d1e101108",
                "type": "#bnf_d1e101108"
            }
        ],
        "#bnf_d1e101148": [
            {
                "id": "bnf_d1e101148",
                "label": "bnf_d1e101148",
                "type": "#bnf_d1e101148"
            }
        ],
        "#bnf_d1e101171": [
            {
                "id": "bnf_d1e101171",
                "label": "bnf_d1e101171",
                "type": "#bnf_d1e101171"
            }
        ],
        "#bnf_d1e18392": [
            {
                "id": "bnf_d1e18392",
                "label": "bnf_d1e18392",
                "type": "#bnf_d1e18392"
            }
        ],
        "interaction": [
            {
                "id": "bnf_int_168",
                "label": "Clarithromycin",
                "type": "interaction"
            },
            {
                "id": "bnf_int_302",
                "label": "Itraconazole",
                "type": "interaction"
            },
            {
                "id": "bnf_int_398",
                "label": "Indinavir",
                "type": "interaction"
            },
            {
                "id": "bnf_int_400",
                "label": "Ritonavir",
                "type": "interaction"
            },
            {
                "id": "bnf_int_791",
                "label": "Saquinavir",
                "type": "interaction"
            },
            {
                "id": "bnf_int_946",
                "label": "Telithromycin",
                "type": "interaction"
            },
            {
                "id": "bnf_int_948",
                "label": "Voriconazole",
                "type": "interaction"
            }
        ],
        "#bnf_d1e58486": [
            {
                "id": "bnf_d1e58486",
                "label": "bnf_d1e58486",
                "type": "#bnf_d1e58486"
            }
        ],
        "#bnf_d1e77847": [
            {
                "id": "bnf_d1e77847",
                "label": "bnf_d1e77847",
                "type": "#bnf_d1e77847"
            }
        ],
        "#bnf_d1e80680": [
            {
                "id": "bnf_d1e80680",
                "label": "bnf_d1e80680",
                "type": "#bnf_d1e80680"
            }
        ],
        "#bnf_d1e82196": [
            {
                "id": "bnf_d1e82196",
                "label": "bnf_d1e82196",
                "type": "#bnf_d1e82196"
            }
        ],
        "#bnf_d1e15839": [
            {
                "id": "bnf_d1e15839",
                "label": "bnf_d1e15839",
                "type": "#bnf_d1e15839"
            }
        ],
        "#bnf_d1e56361": [
            {
                "id": "bnf_d1e56361",
                "label": "bnf_d1e56361",
                "type": "#bnf_d1e56361"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1270",
                "label": "Ponatinib",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75594",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}